<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PGENETICS-D-12-01477</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1002859</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Perspective</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Cancer genetics</subject>
              <subject>Gene function</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Model organisms</subject>
            <subj-group>
              <subject>Animal models</subject>
              <subj-group>
                <subject>Mouse</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Genetics and Genomics</subject>
        </subj-group>
      </article-categories><title-group><article-title>Unmet Expectations: miR-34 Plays No Role in p53-Mediated Tumor Suppression In Vivo</article-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Jain</surname>
            <given-names>Abhinav K</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Barton</surname>
            <given-names>Michelle Craig</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group><aff id="aff1">
        <addr-line>Program in Genes and Development, Center for Stem Cell and Development Biology, Department of Biochemistry and Molecular Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America</addr-line>
      </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Grimes</surname>
            <given-names>H. Leighton</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">
        <addr-line>Cincinnati Children's Hospital Medical Center, United States of America</addr-line>
      </aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">ajain@mdanderson.org</email></corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes><pub-date pub-type="collection">
        <month>7</month>
        <year>2012</year>
      </pub-date><pub-date pub-type="epub">
        <day>26</day>
        <month>7</month>
        <year>2012</year>
      </pub-date><volume>8</volume><issue>7</issue><elocation-id>e1002859</elocation-id><permissions>
        
        <copyright-holder>Jain, Barton</copyright-holder>
        <license xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions><related-article ext-link-type="uri" id="RA1" related-article-type="companion" xlink:href="info:doi/10.1371/journal.pgen.1002797" xlink:type="simple"> <article-title>Intact p53-Dependent Responses in miR-34–Deficient Mice</article-title></related-article><funding-group>
        <funding-statement>The authors received no specific funding for this article.</funding-statement>
      </funding-group><counts>
        <page-count count="3"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title/>
      <p>In vivo modeling of tumor suppressor p53 functions and regulation has a history of unexpected and even enigmatic outcomes <xref ref-type="bibr" rid="pgen.1002859-Spike1">[1]</xref>, despite the status of p53 as the most frequently mutated gene or dysfunctional pathway in human cancers <xref ref-type="bibr" rid="pgen.1002859-Soussi1">[2]</xref>, <xref ref-type="bibr" rid="pgen.1002859-Hollstein1">[3]</xref>. Beginning with the surprising viability of the first mice deleted for <italic>Trp53</italic> <xref ref-type="bibr" rid="pgen.1002859-Harvey1">[4]</xref>, <xref ref-type="bibr" rid="pgen.1002859-Jacks1">[5]</xref>, various hypotheses of compensation, cell type–specificity, stimulus-dependent response, or modifier influences were posed to explain how an exquisitely regulated transcription factor, implicated in a vast array of pathways <xref ref-type="bibr" rid="pgen.1002859-Vousden1">[6]</xref>, appeared to have no impact on development. Limited background-specific developmental and fertility problems do occur, especially in female p53-null mice <xref ref-type="bibr" rid="pgen.1002859-Sah1">[7]</xref>, <xref ref-type="bibr" rid="pgen.1002859-Hu1">[8]</xref>, and deletion of potentially compensatory p53 family members, p63 and p73 isoforms, leads to profound developmental and tissue-specific phenotypes <xref ref-type="bibr" rid="pgen.1002859-Mills1">[9]</xref>, <xref ref-type="bibr" rid="pgen.1002859-Yang1">[10]</xref>. But overall, the most striking result of p53 loss in vivo is early tumor predisposition in p53<sup>−/−</sup> mice, which lack genomic surveillance provided by p53-mediated regulation of cell cycle arrest, apoptosis, and senescence.</p>
      <p>As reported by Concepcion et al. in this issue of <italic>PLoS Genetics</italic> <xref ref-type="bibr" rid="pgen.1002859-Concepcion1">[11]</xref>, expectations built on cell-based studies of p53 response are again unrealized in mouse models. Previously, multiple in vitro analyses suggested that microRNA (miR)-34 family members are important players in a p53-regulated network of genomic surveillance <xref ref-type="bibr" rid="pgen.1002859-Bommer1">[12]</xref>–<xref ref-type="bibr" rid="pgen.1002859-Tarasov1">[17]</xref> (<xref ref-type="table" rid="pgen-1002859-t001">Table 1</xref>). Together, these studies strongly supported the view that p53 response to multiple stimuli depended on miR-34, and that ectopic expression of miR-34 was sufficient to elicit p53 response, consistent with miR-34 functioning as a bonafide tumor suppressor. However, Concepcion et al. report that complete inactivation of the entire family of miR-34 genes (miR-34a/b/c) or knockout of each individual miR-34 gene in mice leads to little or no change in p53-mediated functions in tumor suppression <xref ref-type="bibr" rid="pgen.1002859-Concepcion1">[11]</xref>.</p>
      <table-wrap id="pgen-1002859-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1002859.t001</object-id><label>Table 1</label><caption>
          <title>A list of different in vitro and in vivo model systems used to study miR-34 functions.</title>
        </caption><alternatives>
          <graphic id="pgen-1002859-t001-1" mimetype="image" orientation="portrait" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002859.t001" xlink:type="simple"/>
          <table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">Model System</td>
                <td align="left" colspan="1" rowspan="1">Description</td>
                <td align="left" colspan="1" rowspan="1">miR-34</td>
                <td align="left" colspan="1" rowspan="1">Functional Outcome</td>
                <td align="left" colspan="1" rowspan="1">Ref.</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">mESCs</td>
                <td align="left" colspan="1" rowspan="1">Mouse embryonic stem cells</td>
                <td align="left" colspan="1" rowspan="1">Genetrap-mediated deletion</td>
                <td align="left" colspan="1" rowspan="1">Decreased spontaneous apoptosis during differentiation</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Bommer1">[12]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">NSCLCs</td>
                <td align="left" colspan="1" rowspan="1">Non-small cell lung cancer cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Inhibits growth</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Bommer1">[12]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">SW480</td>
                <td align="left" colspan="1" rowspan="1">p53 mutant colon cancer cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">G1-arrest</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Bommer1">[12]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Wi38</td>
                <td align="left" colspan="1" rowspan="1">Human diploid fibroblasts</td>
                <td align="left" colspan="1" rowspan="1">Depletion</td>
                <td align="left" colspan="1" rowspan="1">Protection from Staurosporine-induced apoptosis</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Bommer1">[12]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">IMR90</td>
                <td align="left" colspan="1" rowspan="1">Primary lung fibroblasts</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Growth inhibition (G1 and G2 arrest), and senescence</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-He1">[13]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">A549</td>
                <td align="left" colspan="1" rowspan="1">Human alveolar adenocarcinoma cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">G1-arrest</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-He1">[13]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">HCT116</td>
                <td align="left" colspan="1" rowspan="1">Human colon cancer cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">G1-arrest</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-He1">[13]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">TOV21G</td>
                <td align="left" colspan="1" rowspan="1">Human ovarian cancer cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">G1-arrest</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-He1">[13]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">MEFs</td>
                <td align="left" colspan="1" rowspan="1">Mouse embryonic fibroblasts</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Apoptosis</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-He1">[13]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">H1299</td>
                <td align="left" colspan="1" rowspan="1">Human lung cancer cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Reduced colony formation</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-RaverShapira1">[14]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">U2OS</td>
                <td align="left" colspan="1" rowspan="1">Human osteosarcoma cells</td>
                <td align="left" colspan="1" rowspan="1">Depletion</td>
                <td align="left" colspan="1" rowspan="1">Reduction in Etoposide-induced apoptosis</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-RaverShapira1">[14]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">HCT116 (p53<sup>+/+</sup> or p53<sup>−/−</sup>)</td>
                <td align="left" colspan="1" rowspan="1">Human colon cancer cells</td>
                <td align="left" colspan="1" rowspan="1">Long-term overexpression</td>
                <td align="left" colspan="1" rowspan="1">Apoptosis</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Chang1">[15]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">HCT116, RKO</td>
                <td align="left" colspan="1" rowspan="1">Human colon cancer cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Suppression of proliferation and induction of senescence</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Tazawa1">[16]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Mouse xenograft model</td>
                <td align="left" colspan="1" rowspan="1">HCT116 or RKO cells were inoculated into nude mice</td>
                <td align="left" colspan="1" rowspan="1">Subcutaneous administration of miR-34a/atelocollagen complexes</td>
                <td align="left" colspan="1" rowspan="1">Suppression of cell proliferation and reduction in tumor volume</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Tazawa1">[16]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">H1299</td>
                <td align="left" colspan="1" rowspan="1">Human lung cancer cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Apoptosis</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Tarasov1">[17]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">U2OS</td>
                <td align="left" colspan="1" rowspan="1">Human osteosarcoma cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">G1-arrest and reduction in colony formation</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Tarasov1">[17]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">MiaPaCa2, BxPC3</td>
                <td align="left" colspan="1" rowspan="1">p53 mutant human pancreatic cancer cell lines</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Inhibited clonogenic cell growth and invasion, induced apoptosis and G1 and G2 arrest; sensitized the cells to chemotherapy and radiation</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Ji1">[34]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">OSN1, OSN2</td>
                <td align="left" colspan="1" rowspan="1">Neoplastic epithelial ovarian cells</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Suppression of proliferation and reduced colony formation</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Corney1">[35]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Kelly, NGP</td>
                <td align="left" colspan="1" rowspan="1">Neuroblastoma cells with MYCN amplification (+MNA)</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Reduction in proliferation and increased apoptosis</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Welch1">[36]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">SK-N-AS</td>
                <td align="left" colspan="1" rowspan="1">Neuroblastoma cells without MYCN amplification (-MNA)</td>
                <td align="left" colspan="1" rowspan="1">Overexpression</td>
                <td align="left" colspan="1" rowspan="1">Reduction in proliferation and increased apoptosis</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Welch1">[36]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Mouse mir34a<sup>−/−</sup>; mir34b/c<sup>−/−</sup></td>
                <td align="left" colspan="1" rowspan="1">miR-34 knockout mouse in C57BL/6 background</td>
                <td align="left" colspan="1" rowspan="1">Germline deletion of miR-34</td>
                <td align="left" colspan="1" rowspan="1">Efficient reprogramming, no effect on proliferation</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Choi1">[30]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">Mouse mir34<sup>TKO</sup></td>
                <td align="left" colspan="1" rowspan="1">miR-34 knockout mouse in129SvJae and C57BL/6 mixed background</td>
                <td align="left" colspan="1" rowspan="1">Germline deletion of miR-34</td>
                <td align="left" colspan="1" rowspan="1">Normal p53 activity</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pgen.1002859-Concepcion1">[11]</xref>
                </td>
              </tr>
            </tbody>
          </table>
        </alternatives></table-wrap>
      <p>Interest in a miR-34 axis as mediator of p53-response begins with the niche that miRNAs fill in regulation of RNA expression. miRNAs are small, regulatory non-coding RNAs that generally mediate post-transcriptional silencing of a number of specific target mRNAs <xref ref-type="bibr" rid="pgen.1002859-Bartel1">[18]</xref>. More than 50% of human miRNA genes are found within cancer-associated or fragile sites of the genome, which suggests that miRNAs play essential roles in tumorigenesis <xref ref-type="bibr" rid="pgen.1002859-Calin1">[19]</xref>. The identification of miRNAs as regulatory targets of p53 <xref ref-type="bibr" rid="pgen.1002859-He2">[20]</xref> suggested their potential involvement in tumor suppression, and expanded the repertoire of p53 downstream targets to both coding and non-coding genes. Further, the view that p53 both positively and negatively regulates gene expression could now rely on increased expression of miRNAs as a mechanism for p53-mediated, indirect repression of gene expression <xref ref-type="bibr" rid="pgen.1002859-He1">[13]</xref>, <xref ref-type="bibr" rid="pgen.1002859-He2">[20]</xref>, in addition to the few documented cases of direct repression by p53 binding to chromatin <xref ref-type="bibr" rid="pgen.1002859-Spurgers1">[21]</xref>–<xref ref-type="bibr" rid="pgen.1002859-Ho1">[25]</xref>.</p>
      <p>The members of the evolutionarily conserved miR-34 family, which arise from three different transcripts at two different gene loci in vertebrates, were the first of several non-coding RNAs identified as directly activated by p53 in response to genotoxic stress <xref ref-type="bibr" rid="pgen.1002859-He1">[13]</xref>, <xref ref-type="bibr" rid="pgen.1002859-Lin2">[26]</xref>. miR-34a is at 1p36, a region commonly deleted in tumors, and miR-34b and miR-34c share a common primary transcript arising from 11q23 <xref ref-type="bibr" rid="pgen.1002859-Versteeg1">[27]</xref>, <xref ref-type="bibr" rid="pgen.1002859-Hermeking1">[28]</xref>. miR-34a, b, and c are expressed at very low levels in several types of cancers <xref ref-type="bibr" rid="pgen.1002859-Hermeking1">[28]</xref>. Previous reports show that p53 directly activates miR-34a/b/c expression and, dependent on cellular context, they act downstream of p53 in mediating cell cycle arrest or apoptosis <xref ref-type="bibr" rid="pgen.1002859-Hermeking2">[29]</xref>. The current list of validated miR-34 downstream targets includes several genes that are repressed during cell cycle arrest or apoptosis when p53 is activated <xref ref-type="bibr" rid="pgen.1002859-Hermeking1">[28]</xref>.</p>
      <p>Given the rationale provided by these studies in cultured cells (<xref ref-type="table" rid="pgen-1002859-t001">Table 1</xref>), multiple laboratories created genetic knockout models of either miR-34a or miR-34b/c, or a compound mutant animal harboring homozygous deletion of all three miR-34 family members (miR-34<sup>TKO</sup>) <xref ref-type="bibr" rid="pgen.1002859-Concepcion1">[11]</xref>, <xref ref-type="bibr" rid="pgen.1002859-Choi1">[30]</xref>. Surprisingly, mice bearing the miR-34 deletion(s) developed normally, are born at the expected Mendelian ratio, and are fertile <xref ref-type="bibr" rid="pgen.1002859-Concepcion1">[11]</xref>. The authors subjected the mice and derived mouse embryonic fibroblasts (MEFs) to a battery of tests to assess any impact on p53-dependent tumor suppression. MEFs obtained from mir-34<sup>TKO</sup> mice have a slightly higher proliferation rate, but reach senescence with kinetics similar to wild-type MEFs. In response to genotoxic threats, miR-34–deficient MEFs are indistinguishable from wild type: they undergo p53-dependent cell cycle arrest and apoptosis. With ectopic expression of oncogenic K-Ras, p53-deficient MEFs are readily transformed, which is not true of K-Ras–expressing miR-34<sup>−/−</sup> MEFs.</p>
      <p>In the intact mouse, the story is similar: aging cohorts of mir-34<sup>TKO</sup> mice remain healthy with no spontaneous tumors, in contrast to p53-null mice <xref ref-type="bibr" rid="pgen.1002859-Harvey1">[4]</xref>. In fact, miR-34–deficient mice remain remarkably healthy and tumor-free for at least 60 weeks after irradiation. Assays of apoptosis in response to irradiation proved positive in tissues of these mice, which additionally exhibited no acceleration of tumor progression in Eμ-models of B-cell lymphomagenesis. All of these assessments of p53 functions in vivo undermine the view that miR-34 functions as a tumor suppressor or is an essential component of the p53-tumor suppression network.</p>
      <p>Although miR-34 proved nonessential in the most highly studied examples of p53 function (senescence, cell cycle arrest, apoptosis, and tumor suppression), it remains possible that miR-34 is involved in other p53-influenced processes, such as metabolism, autophagy, stem cell quiescence, differentiation, and embryogenesis <xref ref-type="bibr" rid="pgen.1002859-Vousden1">[6]</xref>. For example, specific links between miR-34– and p53-regulated functions have been forged in stem cells <xref ref-type="bibr" rid="pgen.1002859-Lin2">[26]</xref>. miR-34–deficient MEFs are more efficiently reprogrammed to induced pluripotent stem cells (iPSCs), by expression of pluripotency factors and c-myc <xref ref-type="bibr" rid="pgen.1002859-Choi1">[30]</xref>, compared to wild-type counterparts. While this study of miR-34 as a barrier to reprogramming does not establish a direct tie to p53, it complements multiple reports that depletion of p53 or dysfunctional p53 pathways enhance the efficiency of reprogramming differentiated, somatic cells to iPSCs <xref ref-type="bibr" rid="pgen.1002859-Krizhanovsky1">[31]</xref>. Recently, we showed that p53 promotes human embryonic stem cell differentiation by direct activation of p21 and miRNAs, including miR-34a, which repress pluripotency factors and SIRT1 <xref ref-type="bibr" rid="pgen.1002859-Jain1">[32]</xref>. Taken together, these results indicate that miR-34 has pro-differentiation effects in maintenance of nontransformed, somatic cells, some of which are p53-dependent.</p>
      <p>In the future, miR-34–deficient mouse models will be valuable in addressing whether miR-34 functions downstream of p53 in a tissue- and/or context-specific manner. miR-34a, miR-34b, and miR-34c share the same seed sequence and target the same RNAs, although differences in target accessibility or binding affinities may dictate their effectiveness. Genome-wide expression analysis may be needed to determine family member–specific effects, such as the reported regulation of c-MYC by miR-34b/c and not miR-34a <xref ref-type="bibr" rid="pgen.1002859-Leucci1">[33]</xref>. Questions of specificity in gene targets for each member of a miRNA family and potential compensation by other miRNAs may be addressed by studies in these and other miRNA mouse models, perhaps still under development. Non-coding RNAs are thought to act in networks that impact diverse cellular pathways, suggesting considerable challenges ahead in asking the right questions and understanding the functional significance of these RNAs.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pgen.1002859-Spike1">
        <label>1</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spike</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Wahl</surname><given-names>GM</given-names></name> (<year>2011</year>) <article-title>p53, stem cells, and reprogramming: tumor suppression beyond guarding the genome</article-title>. <source>Genes Cancer</source> <volume>2</volume>: <fpage>404</fpage>–<lpage>419</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Soussi1">
        <label>2</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Soussi</surname><given-names>T</given-names></name> (<year>2007</year>) <article-title>p53 alterations in human cancer: more questions than answers</article-title>. <source>Oncogene</source> <volume>26</volume>: <fpage>2145</fpage>–<lpage>2156</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Hollstein1">
        <label>3</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hollstein</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sidransky</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vogelstein</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>CC</given-names></name> (<year>1991</year>) <article-title>p53 mutations in human cancers</article-title>. <source>Science</source> <volume>253</volume>: <fpage>49</fpage>–<lpage>53</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Harvey1">
        <label>4</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harvey</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McArthur</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Montgomery</surname><given-names>CA</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Butel</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Bradley</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice</article-title>. <source>Nat Genet</source> <volume>5</volume>: <fpage>225</fpage>–<lpage>229</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Jacks1">
        <label>5</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jacks</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Remington</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>BO</given-names></name>, <name name-style="western"><surname>Schmitt</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Halachmi</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Tumor spectrum analysis in p53-mutant mice</article-title>. <source>Curr Biol : CB</source> <volume>4</volume>: <fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Vousden1">
        <label>6</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vousden</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Prives</surname><given-names>C</given-names></name> (<year>2009</year>) <article-title>Blinded by the light: the growing complexity of p53</article-title>. <source>Cell</source> <volume>137</volume>: <fpage>413</fpage>–<lpage>431</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Sah1">
        <label>7</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sah</surname><given-names>VP</given-names></name>, <name name-style="western"><surname>Attardi</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Mulligan</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>BO</given-names></name>, <name name-style="western"><surname>Bronson</surname><given-names>RT</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>A subset of p53-deficient embryos exhibit exencephaly</article-title>. <source>Nat Genet</source> <volume>10</volume>: <fpage>175</fpage>–<lpage>180</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Hu1">
        <label>8</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Teresky</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>AJ</given-names></name> (<year>2007</year>) <article-title>p53 regulates maternal reproduction through LIF</article-title>. <source>Nature</source> <volume>450</volume>: <fpage>721</fpage>–<lpage>724</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Mills1">
        <label>9</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mills</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>XJ</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Roop</surname><given-names>DR</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>p63 is a p53 homologue required for limb and epidermal morphogenesis</article-title>. <source>Nature</source> <volume>398</volume>: <fpage>708</fpage>–<lpage>713</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Yang1">
        <label>10</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Bronson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kaghad</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Oosterwegel</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours</article-title>. <source>Nature</source> <volume>404</volume>: <fpage>99</fpage>–<lpage>103</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Concepcion1">
        <label>11</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Concepcion</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>Y-C</given-names></name>, <name name-style="western"><surname>Mu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bonetti</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Intact p53-dependent responses in miR-34-deficient mice</article-title>. <source>PloS Genet</source> <volume>8</volume>: <fpage>e1002792</fpage> doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1002797" xlink:type="simple">10.1371/journal.pgen.1002797</ext-link>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Bommer1">
        <label>12</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bommer</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Gerin</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kaczorowski</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Kuick</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>p53-mediated activation of miRNA34 candidate tumor-suppressor genes</article-title>. <source>Curr Biol</source> <volume>17</volume>: <fpage>1298</fpage>–<lpage>1307</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-He1">
        <label>13</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname><given-names>L</given-names></name>, <name name-style="western"><surname>He</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>LP</given-names></name>, <name name-style="western"><surname>de Stanchina</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Xuan</surname><given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A microRNA component of the p53 tumour suppressor network</article-title>. <source>Nature</source> <volume>447</volume>: <fpage>1130</fpage>–<lpage>1134</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-RaverShapira1">
        <label>14</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raver-Shapira</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Marciano</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Meiri</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Spector</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Rosenfeld</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Transcriptional activation of miR-34a contributes to p53-mediated apoptosis</article-title>. <source>Mol Cell</source> <volume>26</volume>: <fpage>731</fpage>–<lpage>743</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Chang1">
        <label>15</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Wentzel</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Kent</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>Ramachandran</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mullendore</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis</article-title>. <source>Mol Cell</source> <volume>26</volume>: <fpage>745</fpage>–<lpage>752</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Tazawa1">
        <label>16</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tazawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tsuchiya</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Izumiya</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakagama</surname><given-names>H</given-names></name> (<year>2007</year>) <article-title>Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>104</volume>: <fpage>15472</fpage>–<lpage>15477</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Tarasov1">
        <label>17</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tarasov</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Verdoodt</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lodygin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Epanchintsev</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest</article-title>. <source>Cell Cycle</source> <volume>6</volume>: <fpage>1586</fpage>–<lpage>1593</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Bartel1">
        <label>18</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bartel</surname><given-names>DP</given-names></name> (<year>2004</year>) <article-title>MicroRNAs: genomics, biogenesis, mechanism, and function</article-title>. <source>Cell</source> <volume>116</volume>: <fpage>281</fpage>–<lpage>297</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Calin1">
        <label>19</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Calin</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Sevignani</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dumitru</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Hyslop</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Noch</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>101</volume>: <fpage>2999</fpage>–<lpage>3004</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-He2">
        <label>20</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname><given-names>L</given-names></name>, <name name-style="western"><surname>He</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Hannon</surname><given-names>GJ</given-names></name> (<year>2007</year>) <article-title>microRNAs join the p53 network–another piece in the tumour-suppression puzzle</article-title>. <source>Nat Rev Cancer</source> <volume>7</volume>: <fpage>819</fpage>–<lpage>822</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Spurgers1">
        <label>21</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spurgers</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Gold</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Coombes</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Bohnenstiehl</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Mullins</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression</article-title>. <source>J Biol Chem</source> <volume>281</volume>: <fpage>25134</fpage>–<lpage>25142</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Lee1">
        <label>22</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Crowe</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Barton</surname><given-names>MC</given-names></name> (<year>1999</year>) <article-title>p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding</article-title>. <source>Mol Cell Biol</source> <volume>19</volume>: <fpage>1279</fpage>–<lpage>1288</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Lin1">
        <label>23</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mazur</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>ME</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression</article-title>. <source>Nat Cell Biol</source> <volume>7</volume>: <fpage>165</fpage>–<lpage>171</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Riley1">
        <label>24</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Riley</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sontag</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>A</given-names></name> (<year>2008</year>) <article-title>Transcriptional control of human p53-regulated genes</article-title>. <source>Nat Rev Mol Cell Bio</source> <volume>9</volume>: <fpage>402</fpage>–<lpage>412</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Ho1">
        <label>25</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ho</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Benchimol</surname><given-names>S</given-names></name> (<year>2003</year>) <article-title>Transcriptional repression mediated by the p53 tumour suppressor</article-title>. <source>Cell Death Differ</source> <volume>10</volume>: <fpage>404</fpage>–<lpage>408</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Lin2">
        <label>26</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Hicks</surname><given-names>GG</given-names></name>, <name name-style="western"><surname>He</surname><given-names>L</given-names></name> (<year>2012</year>) <article-title>The emerging functions of the p53-miRNA network in stem cell biology</article-title>. <source>Cell Cycle</source> <volume>11</volume>: <fpage>2063</fpage>–<lpage>72</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Versteeg1">
        <label>27</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Versteeg</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Caron</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>van der Drift</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Slater</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>1p36: every subband a suppressor?</article-title> <source>Eur J Cancer</source> <volume>31A</volume>: <fpage>538</fpage>–<lpage>541</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Hermeking1">
        <label>28</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hermeking</surname><given-names>H</given-names></name> (<year>2010</year>) <article-title>The miR-34 family in cancer and apoptosis</article-title>. <source>Cell Death Differ</source> <volume>17</volume>: <fpage>193</fpage>–<lpage>199</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Hermeking2">
        <label>29</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hermeking</surname><given-names>H</given-names></name> (<year>2007</year>) <article-title>p53 enters the microRNA world</article-title>. <source>Cancer Cell</source> <volume>12</volume>: <fpage>414</fpage>–<lpage>418</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Choi1">
        <label>30</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>He</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Okada</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>miR-34 miRNAs provide a barrier for somatic cell reprogramming</article-title>. <source>Nat Cell Biol</source> <volume>13</volume>: <fpage>1353</fpage>–<lpage>1360</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Krizhanovsky1">
        <label>31</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Krizhanovsky</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Lowe</surname><given-names>SW</given-names></name> (<year>2009</year>) <article-title>Stem cells: The promises and perils of p53</article-title>. <source>Nature</source> <volume>460</volume>: <fpage>1085</fpage>–<lpage>1086</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Jain1">
        <label>32</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jain</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Allton</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Iacovino</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mahen</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Milczarek</surname><given-names>RJ</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells</article-title>. <source>PLoS Biol</source> <volume>10</volume>: <fpage>e1001268</fpage> doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pbio.1001268" xlink:type="simple">10.1371/journal.pbio.1001268</ext-link>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Leucci1">
        <label>33</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leucci</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cocco</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Onnis</surname><given-names>A</given-names></name>, <name name-style="western"><surname>De Falco</surname><given-names>G</given-names></name>, <name name-style="western"><surname>van Cleef</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation</article-title>. <source>J Pathol</source> <volume>216</volume>: <fpage>440</fpage>–<lpage>450</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Ji1">
        <label>34</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ji</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells</article-title>. <source>PloS ONE</source> <volume>4</volume>: <fpage>e6816</fpage> doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0006816" xlink:type="simple">10.1371/journal.pone.0006816</ext-link>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Corney1">
        <label>35</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Corney</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Flesken-Nikitin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Godwin</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Nikitin</surname><given-names>AY</given-names></name> (<year>2007</year>) <article-title>MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth</article-title>. <source>Cancer Res</source> <volume>67</volume>: <fpage>8433</fpage>–<lpage>8438</lpage>.</mixed-citation>
      </ref>
      <ref id="pgen.1002859-Welch1">
        <label>36</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Welch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Stallings</surname><given-names>RL</given-names></name> (<year>2007</year>) <article-title>MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells</article-title>. <source>Oncogene</source> <volume>26</volume>: <fpage>5017</fpage>–<lpage>5022</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>